---
title: "Mereo Biopharma (MREO.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/MREO.US/norm.md"
symbol: "MREO.US"
name: "Mereo Biopharma"
parent: "https://longbridge.com/zh-CN/quote/MREO.US.md"
datetime: "2026-05-19T21:46:26.607Z"
locales:
  - [en](https://longbridge.com/en/quote/MREO.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MREO.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MREO.US/norm.md)
---

# Mereo Biopharma (MREO.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.0500 | -0.0459 | -0.0439 | -0.0914 | -0.0822 |
| ROE | -71.70% | -67.20% | -55.76% | -102.34% | -85.17% |
| 营业收入 | - | 0.0000 | - | 500000.00 | - |
| 净利润 | -6.72M | -7.35M | -7.02M | -14.62M | -12.89M |
| 营业利润 | -8.67M | -7.92M | -9.87M | -9.75M | -11.02M |
| 毛利率 | - | - | - | 73.60% | - |
| 净利率 | - | - | - | -2923.20% | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 40.61M | 45.92M | 53.60M | 62.63M | 68.32M |
| 权益乘数 | 1.19 | 1.12 | 1.15 | 1.16 | 1.14 |
| 每股净资产 | 0.2133 | 0.2571 | 0.2929 | 0.3407 | 0.3779 |
| 资产周转率 | 0.0092 | 0.0082 | 0.0070 | 0.0063 | - |
| 现金及短投 | 36.22M | 40.99M | 48.70M | 56.13M | 62.48M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 199000.00 | 381000.00 | 552000.00 | 740000.00 | 869000.00 |
| 净债务 | -36.22M | -40.79M | -48.30M | -55.52M | -61.74M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | - | -7.68M | -7.31M | -7.65M | -8.33M |
| 投资现金流 | - | 0.0000 | 300000.00 | 0.0000 | -320000.00 |
| 融资现金流 | - | 39000.00 | 0.0000 | -134000.00 | 422000.00 |
| 自由现金流 | - | -4.65M | -3.92M | -4.41M | -4.97M |
| 现金流充裕率 | - | - | - | - | -41645.00% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | 0.0000 | 0.0000 | 0.0000 | -20000.00 |